Monique L. den Boer - Concepedia

Author

Monique L. den Boer

Erasmus MC - Sophia Children’s Hospital ORCID

Also Known As

Den Boer, M. L., M L Den Boer, M L den Boer, M den Boer, M. L Den Boer, M. L. Den Boer, M. L. den Boer, M. den Boer, M.L. Den Boer, M.L. den Boer

345

Publications

14.8K

Citations

H-Index

Concepts

All Affiliations

Erasmus MC - Sophia Children’s Hospital Erasmus MC Stichting Kinderoncologie Nederland Princess Máxima Center Universität Hamburg

About

Monique L. den Boer is an author at Erasmus MC - Sophia Children’s Hospital specializing in medicine, cell biology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	36	51	7K
2	Health Sciences	10	10	451
3	Natural Sciences	3	3	702
4	Engineering	2	2	101
5	Public Health	1	1	47

Monique L. den Boer

126

Publications

12.9K

Citations

H-Index

Page 1

	Year	Citations
MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia Scott A. Armstrong, Jane Staunton, Lewis B. Silverman, Nature Genetics Hematological MalignancyChromatinDistinct Gene ExpressionMixed-phenotype Acute LeukemiaGenetics	2001	1.7K
A subtype of childhood acute lymphoblastic leukaemia with poor treatment outcome: a genome-wide classification study Monique L. den Boer, Marjon van Slegtenhorst, Renée X. de Menezes, The Lancet Oncology Hematological MalignancyPoor Treatment OutcomePediatric HematologyMedicineGenome-wide Classification Study	2009	915
Gene-Expression Patterns in Drug-Resistant Acute Lymphoblastic Leukemia Cells and Response to Treatment Amy de Haar-Holleman, Meyling Cheok, Monique L. den Boer, New England Journal of Medicine	2004	643
Gene expression-based chemical genomics identifies rapamycin as a modulator of MCL1 and glucocorticoid resistance Guo Wei, David Twomey, Justin Lamb, Cancer Cell Natural SciencesMolecular BiologyResistance Mutation (Virology)Pathway AnalysisGlucocorticoid Resistance	2006	512
Inhibition of FLT3 in MLL Scott A. Armstrong, Andrew L. Kung, Meghann E. Mabon, Cancer Cell Molecular PharmacologyMolecular RegulationMedicineMechanism Of ActionPharmacology	2003	398
Independent prognostic value of BCR-ABL1-like signature and IKZF1 deletion, but not high CRLF2 expression, in children with B-cell precursor ALL Arian van der Veer, Esmé Waanders, Rob Pieters, Blood	2013	290
The MLL recombinome of acute leukemias Claus Meyer, Björn Schneider, Stephan M. Jakob, Leukemia Hematological MalignancyMixed-phenotype Acute LeukemiaHematologyMll RecombinomeMedicine	2006	275
Relation between age, immunophenotype and in vitro drug resistance in 395 children with acute lymphoblastic leukemia–implications for treatment of infants R. Pieters, Monique L. den Boer, M. Durian, Leukemia Hematological MalignancyVitro Drug ResistancePediatric EpidemiologyPediatric HematologyImmunology	1998	242
Inhibition of glycolysis modulates prednisolone resistance in acute lymphoblastic leukemia cells Esther Hulleman, Karin M. Kazemier, Amy de Haar-Holleman, Blood	2008	209
Identification of new microRNA genes and aberrant microRNA profiles in childhood acute lymphoblastic leukemia Diana Schotte, Jacqueline Chau, Giselle Sylvester, Leukemia MedicineGeneticsMixed-phenotype Acute LeukemiaAberrant Microrna ProfilesPathology	2008	199

Page 1